13:19 DAWNRAYS PHARMA<02348> - Results Announcement Dawnrays Pharmaceutical (Holdings) Limited announced on 07/03/2005: (stock code: 02348 ) Year end date: 31/12/2004 Currency: RMB Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 584,758 491,388 Profit/(Loss) from Operations : 86,412 113,233 Finance cost : 0 (809) Share of Profit/(Loss) of Associates : 0 0 Share of Profit/(Loss) of Jointly Controlled Entities : 0 0 Profit/(Loss) after Tax & MI : 80,171 108,022 % Change over Last Period : -25.8 % EPS/(LPS)-Basic (in dollars) : 0.1002 0.1551 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 80,171 108,022 Final Dividend : HK$0.023 HK$0.035 per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 18/04/2005 to 22/04/2005 bdi. Payable Date : 28/04/2005 B/C Dates for Annual General Meeting : 18/04/2005 to 22/04/2005 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Basis of preparation The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board, the disclosure requirements of the Hong Kong Companies Ordinance and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. They have been prepared under the historical cost convention, except for the periodic remeasurement of certain short term listed investment. 2. Basis of consolidation The consolidated financial statements comprise the financial statements of the Company and its subsidiaries. The financial statements of the subsidiaries are prepared using consistent accounting policies. Subsidiaries are consolidated from the date on which control is transferred to the Group and ceased to be consolidated from the date on which control is transferred out of the Group. All significant intercompany transactions and balances within the Group are eliminated on consolidation. Minority interests represent the interests of outside shareholders in the results and net assets of the Company's subsidiaries. The consolidated financial statements for the year ended 31 December 2003 had been prepared by adopting uniting of interests method of accounting as a result of the Group Reorganisation which involved entities under common control. Under this method, the Company had been treated as the holding company of its subsidiaries for the year ended 31 December 2003 rather than from the date of acquisition of the subsidiaries. The consolidated results, statements of changes in equity, cash flows and the consolidated balance sheets of the companies now comprising the Group had been prepared as if the current Group structure had been in existence throughout 2003. 3. Earnings per share The calculation of basic earnings per share is based on the net profit attributable to shareholders for the year of RMB80,171,000 (2003: RMB108, 022,000), and the weighted average of 800,000,000 (2003: 696,438,356) ordinary shares in issue during the year. As the exercise price of outstanding share options is higher than the average fair value of the ordinary share during the year, the conversion to ordinary shares would increase earnings per share. The diluted earnings per share amount for the year ended 31 December 2004 has not been presented, as the share options outstanding during the year had an anti-dilutive effect on the basic earnings per share calculation.